
Seagen
A global biotechnology company dedicated to developing revolutionary therapies with real impact.
Market cap
$43.2b
Enterprise value
$42.0b
Share price
$228.74 SGEN
Authorizing premium user...
A global biotechnology company dedicated to developing revolutionary therapies with real impact.